Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 1/20 | 0.62 |
| ▸ | AOC2 | O75106 | 8/20 | 0.60 |
| ▸ | GAA | P10253 | 1/20 | 0.59 |
| ▸ | RCE1 | Q9Y256 | 1/20 | 0.58 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.44 |
| ▸ | MEN1 | O00255 | 3/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.43 |
| ▸ | MITF | O75030 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | PER2 | O15055 | 1/20 | 0.39 |
| ▸ | MAOB | P27338 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23370190 | 0.96 | AOC2 (0.61) | CYP2C19AOC2GAARCE1PIK3CD | |
| SCHEMBL23370120 | 0.79 | AOC2 (0.55) | CYP2C19AOC2GAARCE1PIK3CD | |
| SCHEMBL23370193 | 0.76 | AOC2 (0.52) | CYP2C19AOC2GAARCE1PIK3CD | |
| SCHEMBL23358536 | 0.76 | AOC2 (1.00) | AOC2MAOB | |
| SCHEMBL23358481 | 0.76 | AOC2 (1.00) | AOC2MAOB | |
| SCHEMBL23358477 | 0.76 | AOC2 (1.00) | AOC2MAOB | |
| SCHEMBL23358482 | 0.76 | AOC2 (1.00) | AOC2MAOB | |
| SCHEMBL11467924 | 0.74 | AOC2 (0.60) | AOC2KMT2AMEN1NPC1MITF | |
| SCHEMBL24907001 | 0.73 | TP53 (0.38) | CYP2C19AOC2GAAKMT2AMEN1 | |
| Hydrochloric Acid SCHEMBL11476141 | 0.73 | AOC2 (0.59) | AOC2KMT2AMEN1NPC1MITF |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210147360-A1 | SSAO INHIBITORS AND USE THEREOF | ECCOGENE INC. | 2021-05-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210147360-A1 | SSAO INHIBITORS AND USE THEREOF | SSB, HAO1, SORD | CYP2C19 664/4885AOC2 39/4885GAA 63/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.